These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6678874)

  • 21. Homoharringtonine: an effective new drug for remission induction in refractory nonlymphoblastic leukemia.
    Warrell RP; Coonley CJ; Gee TS
    J Clin Oncol; 1985 May; 3(5):617-21. PubMed ID: 3889229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alanosine (UCSD).
    Yu J
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1623-30. PubMed ID: 11763167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of acute nonlymphocytic leukemia with neocarzinostatin.
    Griffin TW; Lister TA; Rybak ME; Rosenthal DS; Canellos GP; Woodruff R; Oliver KT
    Cancer Treat Rep; 1979; 63(11-12):1853-6. PubMed ID: 160835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the mechanism of resistance of selected murine tumors to L-alanosine.
    Tyagi AK; Cooney DA; Jayaram HN; Swiniarski JK; Johnson RK
    Biochem Pharmacol; 1981 May; 30(9):915-24. PubMed ID: 7236312
    [No Abstract]   [Full Text] [Related]  

  • 25. A phase II study of aclacinomycin A in acute leukemia in adults.
    Yamada K; Nakamura T; Tsuruo T; Kitahara T; Maekawa T; Uzaka Y; Kurita S; Masaoka T; Takaku F; Hirota Y; Amaki I; Osamura S; Ito M; Nakano N; Oguro M; Inagaki J; Onozawa K
    Cancer Treat Rev; 1980 Dec; 7(4):177-82. PubMed ID: 6938305
    [No Abstract]   [Full Text] [Related]  

  • 26. Rubidazone in adults with previously treated acute leukemia and blast cell phase of chronic myelocytic leukemia: a Southwest Oncology Group Study.
    Bickers J; Benjamin R; Wilson H; Eyre H; Hewlett J; McCredie K
    Cancer Treat Rep; 1981; 65(5-6):427-30. PubMed ID: 6940659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancer.
    Kindler HL; Burris HA; Sandler AB; Oliff IA
    Invest New Drugs; 2009 Feb; 27(1):75-81. PubMed ID: 18618081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anthracyclines in the treatment of acute nonlymphocytic leukemias.
    Boiron M; Jacquillat C; Marty M; Weil M; Gisselbrecht C
    Cancer Treat Rep; 1981; 65 Suppl 4():73-6. PubMed ID: 6955013
    [No Abstract]   [Full Text] [Related]  

  • 29. [Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)].
    Mathé G; de Jager R; Hulhoven R; Delgado M; Machover D; Ribaud P; de Vassal F; Gil-Delgado M; Misset JL; Gouveia J; Jasmin C; Hayat M; Gastiaburu J; Schwarzenberg L
    Nouv Presse Med; 1982 Jan; 11(1):25-8. PubMed ID: 6949137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K; Kaneko Y; Maseki N; Kumai R; Sakurai M; Hattori M
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1453-7. PubMed ID: 4015120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neocarzinostatin: report of a phase II clinical trial.
    McKelvey EM; Murphy W; Zander A; Bodey GP
    Cancer Treat Rep; 1981; 65(7-8):699-701. PubMed ID: 6454486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I--II study of 3-deazauridine in adults with acute leukemia.
    Yap BS; McCredie KB; Keating MJ; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(5-6):521-4. PubMed ID: 7237473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of the antimetabolite of L-alanosine, L-alanosyl-5-amino-4-imidazolecarboxylic acid ribonucleotide, in tumors and assessment of its inhibition of adenylosuccinate synthetase.
    Tyagi AK; Cooney DA
    Cancer Res; 1980 Dec; 40(12):4390-7. PubMed ID: 7438071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rubidazone in the treatment of recurrent acute leukemia in children. A Pediatric Oncology Group Study.
    Ragab AH; Boyett JM; Frankel L; Falletta J
    Cancer; 1986 Apr; 57(8):1461-3. PubMed ID: 3948126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinical trial of pyrazofurin in combination with 5-azacytidine in acute adult nonlymphocytic leukemia.
    Van Echo DA; Chiuten DF; Markus S; Wiernik PH
    Cancer Clin Trials; 1981; 4(2):129-33. PubMed ID: 6166406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Piperazinedione in patients with advanced malignant melanoma: a Southwest Oncology Group study.
    Al-Sarraf M; Thigpen T; Groppe CW; Haut A; Padilla F
    Cancer Treat Rep; 1978 Jul; 62(7):1101-3. PubMed ID: 356973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of CI-973, a platinum analogue, in refractory or relapsed acute leukemia.
    Kantarjian HM; Beran M; O'Brien S; Robertson L; Siddik Z; Yoshida M; Yang LY; Rios MB; Keating MJ; Meyer M
    Leukemia; 1996 Mar; 10(3):396-401. PubMed ID: 8642853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II trial of aclacinomycin in acute leukemia and lymphosarcoma.
    Mathé G; Gil MA; Delgado M; Bayssas M; Gouveia J; Ribaud P; Machover D; Misset JL; de Vassal F; Schwarzenberg L; Jasmin C; Hayat M
    Recent Results Cancer Res; 1980; 74():217-22. PubMed ID: 6893752
    [No Abstract]   [Full Text] [Related]  

  • 39. A phase I trial of carboplatin and etoposide given as continuous infusions to adults with leukemia.
    Lee EJ; Reck K; Carter C; Hodges S; Schiffer CA
    Leukemia; 1993 Oct; 7(10):1500-3. PubMed ID: 8412310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The induction chemotherapy of acute leukemia with a new antileukemic agent "neocarzinostatin" (author's transl)].
    Nagao T; Kamimura O; Takahashi I; Kitajima K; Hiraki K
    Rinsho Ketsueki; 1973 Sep; 14(9):925-30. PubMed ID: 4797130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.